Joel Greenblatt’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.5M | Buy |
142,613
+113,864
| +396% | +$14M | 0.05% | 581 |
|
|
2026
Q1 | $3.39M | Sell |
28,749
-21,782
| -43% | -$3.04M | 0.01% | 964 |
|
|
2025
Q4 | $8.28M | Buy |
50,531
+7,318
| +17% | +$1.15M | 0.03% | 692 |
|
|
2025
Q3 | $5.78M | Buy |
43,213
+19,647
| +83% | +$2.39M | 0.03% | 733 |
|
|
2025
Q2 | $2.93M | Buy |
23,566
+618
| +3% | +$78.6K | 0.02% | 810 |
|
|
2025
Q1 | $2.92M | Buy |
22,948
+16,246
| +242% | +$2.5M | 0.02% | 679 |
|
|
2024
Q4 | $965K | Sell |
6,702
-24,539
| -79% | -$3.52M | 0.01% | 927 |
|
|
2024
Q3 | $4.65M | Buy |
31,241
+13,501
| +76% | +$1.94M | 0.05% | 510 |
|
|
2024
Q2 | $2.24M | Buy |
17,740
+12,955
| +271% | +$2.03M | 0.03% | 652 |
|
|
2024
Q1 | $880K | Buy |
4,785
+33
| +0.7% | +$6.29K | 0.01% | 883 |
|
|
2023
Q4 | $854K | Buy |
4,752
+174
| +4% | +$27.1K | 0.02% | 836 |
|
|
2023
Q3 | $728K | Sell |
4,578
-11,976
| -72% | -$1.96M | 0.02% | 871 |
|
|
2023
Q2 | $2.34M | Buy |
16,554
+11,463
| +225% | +$1.84M | 0.05% | 497 |
|
|
2023
Q1 | $857K | Sell |
5,091
-2,101
| -29% | -$375K | 0.02% | 798 |
|
|
2022
Q4 | $1.22M | Sell |
7,192
-687
| -9% | -$125K | 0.03% | 612 |
|
|
2022
Q3 | $1.47M | Sell |
7,879
-3,056
| -28% | -$644K | 0.04% | 512 |
|
|
2022
Q2 | $1.78M | Buy |
10,935
+3,049
| +39% | +$482K | 0.06% | 408 |
|
|
2022
Q1 | $1.48M | Buy |
7,886
+1,598
| +25% | +$304K | 0.05% | 439 |
|
|
2021
Q4 | $1.67M | Buy |
6,288
+327
| +5% | +$88.1K | 0.05% | 401 |
|
|
2021
Q3 | $1.72M | Sell |
5,961
-769
| -11% | -$197K | 0.07% | 342 |
|
|
2021
Q2 | $1.34M | Hold |
6,730
| – | – | 0.06% | 414 |
|
|
2021
Q1 | $1.31M | Sell |
6,730
-458
| -6% | -$93.9K | 0.06% | 395 |
|
|
2020
Q4 | $1.38M | Sell |
7,188
-1,718
| -19% | -$313K | 0.05% | 449 |
|
|
2020
Q3 | $1.31M | Sell |
8,906
-913
| -9% | -$131K | 0.04% | 463 |
|
|
2020
Q2 | $1.21M | Sell |
9,819
-895
| -8% | -$105K | 0.04% | 512 |
|
|
2020
Q1 | $1.03M | Sell |
10,714
-1,281
| -11% | -$124K | 0.03% | 543 |
|
|
2019
Q4 | $1.11M | Sell |
11,995
-27,703
| -70% | -$2.33M | 0.02% | 602 |
|
|
2019
Q3 | $3.04M | Buy |
39,698
+23,682
| +148% | +$2.07M | 0.05% | 376 |
|
|
2019
Q2 | $1.38M | Sell |
16,016
-6,526
| -29% | -$445K | 0.02% | 573 |
|
|
2019
Q1 | $1.33M | Sell |
22,542
-9,852
| -30% | -$567K | 0.02% | 583 |
|
|
2018
Q4 | $1.71M | Buy |
32,394
+15,587
| +93% | +$914K | 0.03% | 535 |
|
|
2018
Q3 | $932K | Buy |
16,807
+3,696
| +28% | +$190K | 0.01% | 622 |
|
|
2018
Q2 | $617K | Buy |
13,111
+1,553
| +13% | +$63.9K | 0.01% | 664 |
|
|
2018
Q1 | $418K | Sell |
11,558
-12,917
| -53% | -$454K | 0.01% | 739 |
|
|
2017
Q4 | $888K | Sell |
24,475
-94,413
| -79% | -$3.42M | 0.01% | 613 |
|
|
2017
Q3 | $4.56M | Sell |
118,888
-2,737
| -2% | -$115K | 0.07% | 386 |
|
|
2017
Q2 | $5.04M | Sell |
121,625
-5,439
| -4% | -$207K | 0.07% | 357 |
|
|
2017
Q1 | $4.47M | Sell |
127,064
-2,495
| -2% | -$79K | 0.06% | 412 |
|
|
2016
Q4 | $3.99M | Sell |
129,559
-10,957
| -8% | -$339K | 0.05% | 414 |
|
|
2016
Q3 | $4.24M | Buy |
140,516
+80,799
| +135% | +$2.44M | 0.06% | 383 |
|
|
2016
Q2 | $1.63M | Buy |
59,717
+22,522
| +61% | +$576K | 0.02% | 553 |
|
|
2016
Q1 | $998K | Buy |
37,195
+13,243
| +55% | +$324K | 0.01% | 659 |
|
|
2015
Q4 | $678K | Sell |
23,952
-1,436
| -6% | -$41.4K | 0.01% | 657 |
|
|
2015
Q3 | $707K | Buy |
+25,388
| New | +$917K | 0.01% | 675 |
|
|
2015
Q1 | – | Sell |
-13,954
| Closed | -$276K | – | 999 |
|
|
2014
Q4 | $276K | Buy |
13,954
+1,083
| +8% | +$24.2K | ﹤0.01% | 845 |
|
|
2014
Q3 | $256K | Sell |
12,871
-2,043
| -14% | -$43K | ﹤0.01% | 880 |
|
|
2014
Q2 | $340K | Sell |
14,914
-590
| -4% | -$10.5K | ﹤0.01% | 858 |
|
|
2014
Q1 | $199K | Sell |
15,504
-3,028
| -16% | -$43.4K | ﹤0.01% | 981 |
|
|
2013
Q4 | $253K | Buy |
+18,532
| New | +$221K | 0.01% | 893 |
|
Other funds holding RGEN
UCFA
MC
WA
Joel Greenblatt's RGEN Position: Q2 2026 in Review
Joel Greenblatt increased its Repligen (RGEN) stake by 396% in Q2 2026, buying an estimated $14M and bringing the position to 142,613 shares worth $19.5M. The position accounts for 0.05% of the portfolio, ranked #581.
Joel Greenblatt first reported a position in RGEN in Q4 2013 and has held it in 49 quarters since. 476 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Joel Greenblatt held 142,613 shares of Repligen worth $19.5M as of Q2 2026.
- Joel Greenblatt bought 113,864 Repligen shares in Q2 2026, an estimated $14M.
- Repligen made up 0.05% of Joel Greenblatt's portfolio in Q2 2026, its #581 holding.
- Joel Greenblatt first reported a position in Repligen in Q4 2013 and has held it in 49 quarters since.
- 476 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.